Infants in low- and middle- income countries (LMIC) are disproportionately burdened by bacterial diarrheal diseases and infections with antimicrobial resistance (AMR). Bacterial diarrheal pathogens contributes significantly to infant mortality, with many classified as WHO AMR priority pathogens. Interventions are needed to prevent infections with bacterial enteropathogens and AMR.
Our previous research showed that there are differences in the E coli colonization of infants’ microbiome between LMIC vs. high-income countries (HIC). The airm of this PhD project is to understand how E. coli colonization contributes tot he risk of diarrheal disease and infections with AMR and use this knowledge to design interventions that protectLMIC infants from both.
This is a 4 year PhD project based at the Amsterdam UMC's Department of Global Health, building on collaborations with the Centers for Infectious DIsease Research in Zambia, the University of Ghana, and Kenya Medicral Research Institute.
Would you like to know more about the different phases within the PhD trajectory? You can read more about this on this page.
The PhD student will first use existing datasets to identify bacterial, host and environmental determinants of E. coli carriage, bacterial diarrheal infections, and AMR gene (ARG) carriage in infants. They will then support two clinical studies in Kenya and Zambia, assessing whether E. coli carriage contributes to Enterobacteriaceae colonization and ARG transmission. Finally, the PhD student will use agent-based modeling to simulate colonization resistance and ARG transmission dynamics, guiding the design of microbiome-based interventions. Collectively, this work will clarify the role of E. coli in infant gut ecology, support dvelopment of ARG endpoints in late-stage enteric vaccine trials and identify new strategies to reduce AMR and bacterial infections in at-risk LMIC infants.
We are looking for an ambitious PhD candidate to study the interaction between E coli carriage, bacterial gastroenteritis and risk of AMR infections in infants in LMIC settings.
Supportive expertise for the position include:
Key qualities for the researcher include:
Watch this video with more information about joining Amsterdam UMC Research BV.
The Department of Global Health at Amsterdam UMC is an internationally oriented, multidisciplinary department dedicated to improving health and reducing health inequalities worldwide. Its research brings together epidemiology, infectious diseases, public health, data science, implementation research and social science, with a strong focus on health challenges affecting populations in low- and middle-income countries. Through long-standing international partnerships, the department combines rigorous scientific research with clinical and public health practice and provides a highly collaborative environment for training the next generation of global health researchers.
Amsterdam UMC is one of the largest academic medical centres in the Netherlands, bringing together more than 19,500 employees across two main locations, AMC and VUmc, and representing the medical faculties of both the University of Amsterdam and Vrije Universiteit Amsterdam. It integrates academic patient care, research and education and is home to eight research institutes covering the full spectrum of biomedical and health research. Researchers benefit from extensive core facilities, modern data infrastructure, methodological and statistical support, clinical research facilities, grant and data-management support, and strong links between laboratory, computational, clinical and population-based research.
The PhD candidate will be embedded within the Amsterdam Institute for Immunology and Infectious Diseases (AI&I), one of Amsterdam UMC's eight research institutes. AI&I brings together researchers working across two major scientific programmes—Immunology and Infectious Diseases—with the aim of translating fundamental and clinical discoveries into improved prevention, diagnosis and treatment of disease. The Infectious Diseases programme is organised around four interconnected themes: Host–Microbe Interaction, Public & Global Health, Diagnostics & Therapeutics, and Vaccines & Other Preventive Strategies, with antimicrobial resistance as one of its central research topics. AI&I provides an active interdisciplinary research community with seminars, PhD activities, scientific networks and opportunities for collaboration across Amsterdam UMC, UvA, VU Amsterdam and partner institutes including AIGHD.
Together, this provides a stimulating environment for a PhD candidate working at the interface of microbiome science, infectious diseases, antimicrobial resistance and global child health. The candidate will have opportunities to combine advanced data analysis and computational modeling with clinical research in Kenya and Zambia, while working within an international network of microbiologists, clinicians, epidemiologists, bioinformaticians and qualitative scientists.
Amsterdam UMC Research BV
Amsterdam UMC Research BV supports non-profit scientific research. In doing so, we provide researchers with everything they need to excel. Our principal investigators (PIs) and project leaders offer support in the field of project management, finance and human resources. In medical scientific research projects, legal support is also provided.
Watch the video to find out more.
During the publication period, applications will be handled continuously. If the vacancy is filled, it will be closed prematurely.
If you have any questions about this position, please feel free to contact Dr. Vanessa Harris, v.c.harris@amsterdamumc.nl
A reference check, screening and hiring assessment may be part of the procedure. Read here whether that applies to you. If you join us, we ask you for a VOG (Certificate of Good Conduct).
Internal candidates will be given priority over external candidates in case of equal suitability.
Acquisition in response to this vacancy will not be considered.


